Search companies

Live

Wednesday, 18 November 2026 · 632 Summaries Today

S&P/ASX 200 · 8,821.80 (-0.69%)

Compumedics Targets Double-Digit FY27 Growth After Record Sales

CMP: $0.235 +2.17% · MC: $48M

Compumedics reported record FY26 sales, up 18.5%, while EBITDA rose 74% and cash from operations increased from $0.4 million to $6.6 million. For FY27, it aims for double-digit sales growth and faster EBITDA growth, with over $28 million of orders to deliver; these are company objectives, not a forecast. At its AGM, shareholders re-elected Rod North and adopted the Remuneration Report.

Source announcements: 2026-10-29 13:40 to 2026-10-29 15:51 Sydney time
Story updated 2026-10-29 15:54 Sydney time
SourcesChair's Address to ShareholdersResults of Meeting
Comments